MDxHealth, Inc.: Extraordinary General Shareholders’ Meeting

Published: Jun 15, 2012

IRVINE, Calif. & LIEGE, Belgium--(BUSINESS WIRE)--Regulatory News: MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostic company that develops and commercializes epigenetic tests to support cancer treatment, held its Extraordinary General Meeting of shareholders in Zaventem today. The shareholders approved all agenda items of the Extraordinary General Meeting of shareholders.

Back to news